Abstract
Background:Sodium-glucose cotransporter-2 inhibitors improve heart failure–related outcomes. The mechanisms underlying these benefits are not well understood, but diuretic properties may contribute...
Cite
CITATION STYLE
APA
Griffin, M., Rao, V. S., Ivey-Miranda, J., Fleming, J., Mahoney, D., Maulion, C., … Testani, J. M. (2020). Empagliflozin in Heart Failure. Circulation, 142(11), 1028–1039. https://doi.org/10.1161/circulationaha.120.045691
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free